Cancer Prevention / Control

  • URCC 10055– Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-treatment, Post-Treatment, and at Six Month Follow-up
  • ALLIANCE Z11102– Phase II Study of Impact of Breast-Conserving Surgery and Radiotherapy in Patients with Multiple Ipsilateral Breast Cancers (MIBC)
  • SWOG S0820– A Double Blinded Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage O-III Colon Cancer Phase III-Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)
  • ECOG E1Z11- A Cohort Study to Evaluate Anastrozole in Treating Aromatase Inhibitor Musculoskeletal Symptoms in Women with Stage I-III Breast Cancer (only open to Asian and African-Americans)
  • URCC 13059– A Geriatric Assessment Intervention for Patients Aged 70 and Over Receiving Chemotherapy for Advanced Cancer: Reducing Chemotherapy Toxicity in Older Adults
  • URCC 13070– Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
  • ALLIANCE A011104– Study reviewing the effect of Preoperative Breast MRI on Surgical Outcomes. Costs and Quality of Life of Women with Breast Cancer
  • RTOG 0631– Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis
  • WFU 98213– Preventing Anthracycline Cardiovascular Toxicity with Statins (PREVENT)
  • URCC 14079– Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
  • GOG 0225– Can Diet and Physical Activity Modulate Ovarian Fallopian Tube and Primary Peritoneal Cancer Progression?
  • WFU 97115– A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer
  • ACCRU RU221501I– A Phase III Randomized Open label Study Evaluating the Safety of Apixaban in Subjects with Cancer Related Venous Thromboembolism
  • ECOG-ACRIN E4112– Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma in Situ (DCIS)
  • NRG-CC001– A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy with or without Hippocampal Avoidance in Patients with Brain Metastasis
  • NRG-CC003– A Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer
  • Alliance A011401– A Randomized Phase III Trial Evaluation The Role of Weight Loss In Adjuvant Treatment of Overweight and Obese Women with Early Stage Breast Cancer